Okamoto, Masahiro <br/><br/>
Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.  [electronic resource] 

 -  Ophthalmic surgery, lasers & imaging retina  Jan 2015 
 - 25-32 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>2325-8179 
<br/><br/><label>Standard No.: </label>10.3928/23258160-20150101-04  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Bevacizumab<br/>Blood Flow Velocity<br/>Blood Pressure--physiology<br/>Central Serous Chorioretinopathy--diagnosis<br/>Choroid--physiopathology<br/>Chronic Disease<br/>Coloring Agents<br/>Female<br/>Fluorescein Angiography<br/>Heart Rate<br/>Humans<br/>Indocyanine Green<br/>Intraocular Pressure--physiology<br/>Intravitreal Injections<br/>Laser-Doppler Flowmetry<br/>Male<br/>Middle Aged<br/>Organ Size<br/>Prospective Studies<br/>Regional Blood Flow<br/>Retina--pathology<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology